Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury
Status:
Approved for marketing
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The overall purpose of this study is to determine if replacing standard soybean oil based fat
emulsions with Omegaven®, a fish oil based fat emulsion, can reverse or prevent the
progression of parenteral nutrition associated cholestasis. It is a compassionate use
protocol for patients who already have significant cholestasis related to parenteral
nutrition.
Details
Lead Sponsor:
Jeffrey Rudolph University of Pittsburgh
Collaborators:
Children's Hospital of Pittsburgh University of Pittsburgh